Skip to main content
Figure 6 | BMC Medical Informatics and Decision Making

Figure 6

From: Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers

Figure 6

Decision curve for survival time data with and without adjustment for competing risk, where the incidence of competing risks is high (bladder cancer data set). The thick grey line is the net benefit for a strategy of treating all patients with (dashed line) and without (solid line) adjustment for competing risk; the thin black line is the net benefit of a strategy of treating patients according to the model with (dashed line) and without (solid line) adjustment for competing risk; the thick black line is the net benefit of treating no patients.

Back to article page